He Found a 15.1% Yield HMO Nobody Else Could See

The Manchester Trap: When Popularity Destroys Returns

Picture the average new property investor in 2025. They've done six months of YouTube research. They've joined three Facebook groups. And every single one of those groups is talking about Manchester, Liverpool, and Leeds.

So they pile in. Rightmove alerts set. Spreadsheets built. Offers made. And then — nothing. Outbid. Outbid again. Or worse: they win the deal, only to discover the numbers only work on paper if you strip out voids, management fees, and the inevitable licensing compliance costs.

Foot Forward Properties, who track saturation signals across UK HMO markets, put it plainly: Manchester and Liverpool are now increasingly challenging and competitive for new HMO investors. That's a polite way of saying the easy money left years ago.

The mistake isn't doing HMOs. The mistake is confusing name recognition with opportunity.

What the Data Actually Says: 15.1% vs 8.0%

Close-up of a clean wooden desk with a single open notebook, a pen resting beside it, and a simple printed map of UK regions with coloured circles of varying sizes indicating relative yield strength — the North East circle the largest and warmest in colour. Soft morning window light, shallow depth of field, calm and focused mood. No text, numbers, letters, or logos visible.

Hiten Ganatra of Visionary Finance published yield data in what MORTGAGE in March 2026 that should have stopped every Manchester-obsessed investor in their tracks.

The North East: average HMO yield of 15.1%.

London: 8.0%. The lowest in the country — despite average HMO values hitting £684,724 and annual rents reaching £55,017.

Read that again. London landlords are collecting £55,000 a year in rent and still delivering the worst yield in the UK. Because the capital tied up in those assets is enormous. Yield is a ratio, not a revenue figure — and that distinction is exactly what most new investors get wrong.

The North East doesn't have London's glamour or Manchester's hype. What it has is a ratio that almost doubles the capital's return. And for a well-run HMO — which Quartico noted in April 2026 can deliver 8–12% even in moderate markets — a North East deal at the top of that range is genuinely life-changing math.

I'm not saying London deals are bad. I'm saying chasing postcode prestige instead of yield arithmetic is how investors stall their portfolios for years.

The Real Problem Isn't Knowledge — It's Discovery

Here's what the yield data doesn't solve on its own: finding an actual deal.

Knowing the North East yields 15.1% doesn't tell you which streets, which property types, which HMOs are coming to market — or which ones are sitting off-market entirely. That's the gap between reading a yield report and actually buying a property.

HMOs are genuinely harder to find than standard buy-to-let. They don't always appear on Rightmove in a clean, filterable format. Licensing status, room counts, current tenancy structures — none of that is surfaced neatly by the major portals. Investors either rely on agents who may or may not specialise, or they spend hours manually cross-referencing data that should be in one place.

This is the exact problem [ZARSK](https://zarsk.co.uk) was built to solve. The database is — as far as I can tell — the largest live HMO database in the UK, constantly updated. Not a static list. Not a quarterly report. A live feed of opportunities that surfaces what the standard portals miss.

When new investors first try to find HMOs manually, the common pattern is wasted weeks on properties that either aren't genuine HMOs, don't stack financially, or were already under offer before they arrived. A purpose-built database changes that equation entirely.

The Financing Piece Nobody Talks About Enough

Finding the deal is step one. Funding it is where portfolios actually stall.

HMO mortgages are a specialist product. High street lenders often won't touch them, or they'll offer terms that make the yield arithmetic collapse. For a first-time HMO investor, getting a competitive product without a specialist broker is genuinely difficult — not impossible, but the difference between a good rate and a mediocre one can cost thousands annually.

For existing portfolio holders, the challenge is different but equally real: freeing equity from a portfolio of buy-to-lets or existing HMOs to fund the next acquisition. I've spoken to landlords sitting on significant unrealised equity who simply couldn't get a lender to structure it efficiently. That's not a property problem. That's a finance problem — and it needs a finance specialist, not a generalist.

ZARSK's regulated mortgage partners have been operating in this space for over a decade. They're not generalists who occasionally do a BTL. They work specifically with HMO investors, including those trying to unlock equity from existing portfolios to scale. If you've ever been told 'the numbers don't work' by a high street lender on an HMO deal, it's worth having a conversation with someone who does this every day. You can explore that at [zarsk.co.uk/finance-property](https://www.zarsk.co.uk/finance-property).

Consider consulting a qualified financial adviser before making any mortgage or equity release decision — what works for one portfolio structure won't suit another.

The 15.1% yield figure isn't a secret — it's published data. But most investors will read it, nod, and then go back to refreshing Rightmove for Manchester terraces. That gap between knowing and acting is where the real opportunity lives. Data tells you where to look. A purpose-built database gets you the actual deal. Specialist finance gets it funded. The investor who figures out how to connect all three — that's the one who builds a portfolio that actually performs.